CHIARI, Rita
 Distribuzione geografica
Continente #
NA - Nord America 1.004
AS - Asia 699
EU - Europa 625
SA - Sud America 110
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.459
Nazione #
US - Stati Uniti d'America 980
SG - Singapore 295
IT - Italia 152
CN - Cina 127
IE - Irlanda 125
VN - Vietnam 94
BR - Brasile 84
HK - Hong Kong 79
DE - Germania 71
RU - Federazione Russa 70
FR - Francia 52
FI - Finlandia 33
RO - Romania 29
IN - India 23
GB - Regno Unito 22
UA - Ucraina 21
CA - Canada 16
KR - Corea 14
PL - Polonia 11
BD - Bangladesh 10
SE - Svezia 10
IQ - Iraq 9
JP - Giappone 9
AR - Argentina 8
TR - Turchia 8
EC - Ecuador 6
MA - Marocco 6
MX - Messico 6
CH - Svizzera 5
ZA - Sudafrica 5
CL - Cile 4
JO - Giordania 4
LT - Lituania 4
VE - Venezuela 4
AT - Austria 3
ES - Italia 3
ET - Etiopia 3
ID - Indonesia 3
NL - Olanda 3
OM - Oman 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
BE - Belgio 2
BO - Bolivia 2
EG - Egitto 2
EU - Europa 2
NP - Nepal 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CR - Costa Rica 1
DZ - Algeria 1
GR - Grecia 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
ME - Montenegro 1
MT - Malta 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SI - Slovenia 1
TH - Thailandia 1
TN - Tunisia 1
Totale 2.459
Città #
Singapore 216
Chandler 164
Dublin 125
San Jose 98
Hong Kong 79
Ashburn 68
Perugia 66
San Mateo 66
Dong Ket 44
Beijing 37
Boardman 35
Santa Clara 34
Altamura 33
Bucharest 28
Munich 28
Medford 24
Princeton 24
Lawrence 23
Moscow 23
Houston 21
Ho Chi Minh City 20
Lauterbourg 20
Helsinki 17
Los Angeles 17
Seoul 14
Andover 13
The Dalles 13
Wilmington 13
New York 12
Frankfurt am Main 10
Jacksonville 10
Nuremberg 10
Redmond 10
San Paolo di Civitate 9
Ann Arbor 8
Hanoi 8
Stockholm 8
Tokyo 8
Warsaw 8
São Paulo 7
Des Moines 6
Falkenstein 6
Saint Petersburg 6
Turku 6
Brooklyn 5
Calgary 5
Curitiba 5
Denver 5
Ottawa 5
Phoenix 5
Amman 4
Baghdad 4
Dhaka 4
Erbil 4
Mumbai 4
Nanjing 4
New Delhi 4
Orem 4
Poplar 4
Rio de Janeiro 4
Seattle 4
Atlanta 3
Bắc Ninh 3
Caracas 3
Chennai 3
Columbus 3
Dallas 3
Guayaquil 3
Johannesburg 3
Manassas 3
Manchester 3
Mexico City 3
Montreal 3
Norwalk 3
Piscataway 3
Redwood City 3
Rome 3
San Francisco 3
Bexley 2
Boston 2
Brasília 2
Brussels 2
Goiânia 2
Hefei 2
Hải Dương 2
Istanbul 2
Kanpur 2
Kansas City 2
London 2
Londrina 2
Muscat 2
Nazrēt 2
Pietralunga 2
Piracicaba 2
Santa Fe 2
Suzhou 2
Torgiano 2
Vilnius 2
Addis Ababa 1
Aksaray 1
Totale 1.662
Nome #
Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications 193
Gene identification for risk of relapse in stage I lung adenocarcinoma patients: A combined methodology of gene expression profiling and computational gene network analysis 128
Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer 128
Alectinib's activity against CNS metastases from ALK-positive non-small cell lung cancer: a single institution case series 119
Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool 117
Targeting indoleamine-2,3-dioxygenase in cancer: Scientific rationale and clinical evidence 112
Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer 108
Large Cell Neuroendocrine Carcinoma Transformation and EGFR-T790M Mutation as Coexisting Mechanisms of Acquired Resistance to EGFR-TKIs in Lung Cancer 107
Higher tlr7 gene expression predicts poor clinical outcome in advanced nsclc patients treated with immunotherapy 106
Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET, and non-sensitizing EGFR mutations. 104
Precision medicine against ALK-positive non-small cell lung cancer: beyond crizotinib 98
Osimertinib 96
Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer 94
Long-term survival with erlotinib in advanced lung adenocarcinoma harboring synchronous EGFR G719S and KRAS G12C mutations 90
Fatal acute disseminated intravascular coagulation as presentation of advanced ALK-positive non-small cell lung cancer: Does oncogene addiction matter? 90
Emerging enzymatic targets controlling angiogenesis in cancer: preclinical evidence and potential clinical applications 89
EGFR, KRAS, PIK3CA mutations and response to tyrosine kinase inhibitors (TKIs) in advanced NSCLC patients. 87
Texture Analysis on [18F]FDG PET/CT in Non-Small-Cell Lung Cancer: Correlations Between PET Features, CT Features, and Histological Types 87
How might treatment of ALK-positive non-small cell lung cancer change in the near future? 85
MiRNAs and resistance to EGFRâ€"TKIs in EGFR-mutant non-small cell lung cancer: Beyond 'traditional mechanisms' of resistance 84
Validity of ICD-9-CM codes for breast, lung and colorectal cancers in three Italian administrative healthcare databases: a diagnostic accuracy study protocol 83
Survival outcomes and incidence of brain recurrence in high-grade neuroendocrine carcinomas of the lung: Implications for clinical practice 82
Malignant giant solitary fibrous tumor of the pleura metastatic to the thyroid gland 82
Targeting NTRK fusion in non-small cell lung cancer: rationale and clinical evidence 71
Assessment of TILs, IDO-1 and PD-L1 in resected non small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications. 55
Safety and Efficacy of Nivolumab in Patients With Advanced Non-small-cell Lung Cancer Treated Beyond Progression 47
Totale 2.542
Categoria #
all - tutte 11.259
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.259


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202148 0 0 0 0 0 0 0 0 0 0 4 44
2021/2022251 1 47 2 4 1 2 2 66 30 21 34 41
2022/2023482 26 109 5 39 37 42 0 30 175 0 15 4
2023/2024192 11 12 9 8 0 2 55 1 8 4 43 39
2024/2025373 10 29 41 7 39 24 9 35 68 22 57 32
2025/2026928 58 63 46 126 158 85 144 49 104 76 19 0
Totale 2.542